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Introduction
The relationship between autonomic nervous system
(ANS) dysfunction and familial Mediterranean fever
(FMF) is controversial. Heart rate variability (HRV) is a
powerful, simple and reliable technique for the evaluation
of ANS dysfunction. Recently, we reported on normal
HRV parameters, suggestive of normal ANS function, in
patients with uncomplicated FMF. Also, we reported on
an association between decreased HRV parameters (sug-
gestive of ANS dysfunction), and amyloidosis of FMF,
particularly at a progressive stage.
Objectives
The aim of the current study was to evaluate whether
FMF patients, who do not respond to colchicine treat-
ment, and thereby endure persistent inflammation, have
abnormal ANS function, using the HRV tool.
Methods
Twenty-four FMF patients suffering from recurrent FMF
attacks despite treatment with a maximal colchicine
dose, were selected for the study. Electrocardiogram was
measured under strict conditions and HRV parameters
were calculated. Results were compared with age- and
sex- matched unaffected controls.
Results
No statistically significant difference was found between
the groups in any determined HRV parameter: maximal
RR, minimal RR and average RR intervals, standard devia-
tion of RR interval, square root of the mean squared differ-
ences of successive RR intervals, HRV triangular index,
NN50, pNN50, and power spectral analysis. Nevertheless, a
statistically non-significant trend towards lower HRV
parameters was observed in the colchicine non-responders
group.
Conclusion
Although a small difference in HRV parameters cannot
be entirely excluded in the current study design, FMF
patients, in whom colchicine did not provide adequate
symptomatic relief and who did not develop amyloido-
sis, seem to have HRV parameters similar to those of
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